Display search results for ** instead (3496 products)
02 Mar 2021  |  North America
Developing Innovative ROI Streams and Patient-centric Virtual Care Approaches will Shape the Global Healthcare Industry, Outlook 2021
Digital Transformation Leads to New Growth Strategies for Stakeholders
The global COVID-19 pandemic and other geo-political events left many businesses facing an unprecedented state of uncertainty. Healthcare companies across the care continuum remain grappling with these new challenges, of which the extent and longevity remain unknown. Spurred by the years events, healthcare delivery has accelerated its transformatio...
26 Feb 2021  |  Global
INNOVATIONS AND GROWTH OPPORTUNITIES IN NEUROSTIMULATION DEVICES, ADVANCED DIAGNOSTICS, AND DIGITAL THERAPY PLATFORMS
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations cover various neuromodulation technologies for the treatment of various diseases. The issue also profiles various advanced diagnostics and emerging digital therapeutics ...
23 Feb 2021  |  North America
AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market
Increased Demand for Remote Pathology Services and Centralization of Digital Pathology Workflow in Hospital Networks to Spark New Growth Opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the global digital pathology market, highlighting key growth opportunities, market revenue forecast, and business models that will play an essential role in its growth. The study segments the market by product (hardware, software, and storage solutions) and region ...
19 Feb 2021  |  Global
GROWTH OPPORTUNITIES IN TARGETED CANCER THERAPY & CANCER DIAGNOSTICS, VIRAL VECTORS, MULTIPLE DISEASES, RETINAL DISEASES, AND COSMECEUTICALS
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) discusses developments in cancer diagnostics and targeted cancer therapy, therapeutics for MDR bacteria, viral vectors, and antibody therapeutics for multiple diseases. Further, innovations in emerging technologies such as synthetic blood and 3D printed implant...
19 Feb 2021  |  North America
Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market
High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential
Frost & Sullivan’s Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries’ biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities...
16 Feb 2021  |  North America
Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market
Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care
Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...
15 Feb 2021  |  North America
Growth Strategies Driven by Breakthrough Technologies
As the need and preference for minimally invasive surgeries are rapidly rising, the demand for endoscopic procedures is also witnessing substantial growth. Since endoscopes are minimally invasive and use the natural openings of the body for insertion to aid physicians with enhanced images for the purpose of diagnosis and therapy, the need for scope...
11 Feb 2021  |  Europe
Expansion in Consumer Health and Improved Access to Care Spur New Growth Opportunities
As the rapid spread and impact of COVID-19 continue to cripple healthcare sector providers across Europe, telehealth is emerging as a boon in ensuring efficient access to essential healthcare services. Primary care appointments took a major downturn as people avoided them largely until necessary or were unable to have routine face-to-face visits du...
09 Feb 2021  |  North America
Competitors’ Growth Strategies will Shape the Way the Market Opportunity Crystallizes
There is no one definition for virtual care, but Frost & Sullivan defines it in this research as a technical platform that maintains an interactive connectivity between patients, providers, and payers where various processes and services may be scheduled, accessed, monitored, and entered into the medical record without the need for manual calls or ...
05 Feb 2021  |  North America
Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market
Early-stage R&D and Commercial Applications Fuel the Growth Pipeline
The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...